Expression of mucins, SIMA, villin, and CDX2 in small-intestinal adenocarcinoma

被引:34
|
作者
Zhang, Megan Q.
Lin, Fan
Hui, Pei
Chen, Zong-Ming E.
Ritter, Jon H.
Wang, Hanlin L.
机构
[1] Washington Univ, Sch Med, Dept Pathol & Immunol, Lauren V Ackerman Lab Surg Pathol, St Louis, MO USA
[2] Geisinger Med Ctr, Dept Lab Med, Danville, PA 17822 USA
[3] Yale Univ, Sch Med, Dept Pathol, New Haven, CT 06510 USA
关键词
small intestine; colorectal; adenocarcinoma; mucin; small-intestinal mucin antigen; villin; CDX2;
D O I
10.1309/JAF3KVGJHQCJ1QF9
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Expression of gastrointestinal biomarkers MUCI, MUC2, MUC5AC, small-intestinal mucin antigen (SIMA), villin, and CDX2 has been studied in colorectal adenocarcinoma (CRC). Little is known, however, about their expression in small-intestinal adenocarcinoma (SIA). We immunohistochemically compared 30 SIAs with 48 CRCs for the expression of these biomarkers. The results showed that all 6 proteins were variably expressed in SIA, but the frequencies of expression were significantly lower than those for CRC with the exception of MUC1 Specifically, positive staining for MUCI, MUC2, MUC5AC, SIMA villin, and CDX2 was observed in 16 (53%), 17 (57%), 12 (40%), 15 (50%), 20 (67%), and 18 (60%) of SlAs and 25 (52%), 43 (90%), 39 (81%), 45 (94%), 47 (98%), and 47 (98%) of CRCs, respectively. In addition, SIAs morefrequently exhibited afocal staining pattern for MUC2, MUC5AC, SIMA, and villin, whereas more diffuse immunoreactivity was evident in CRCs. Focal staining for MUCI and diffuse staining for CDX2 were common for SIAs and CRCs. Furthermore, poorly differentiated SIAs tended to express MUCI more frequently when compared with well- and moderately differentiated SIAs. These observations further support the notion that SIA is immunophenotypically distinct from CRC despite their morphologic similarity.
引用
收藏
页码:808 / 816
页数:9
相关论文
共 50 条
  • [41] Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures
    Wang, Xiao-Tong
    Wei, Wei-Yuan
    Kong, Fan-Biao
    Lian, Chao
    Luo, Wen
    Xiao, Qiang
    Xie, Yu-Bo
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2012, 31
  • [42] Association of CDX2 and mucin expression with chemotherapeutic benefits in patients with stage II/III gastric cancer
    Gao, Xianchun
    Han, Weili
    Chen, Ling
    Li, Hongwei
    Zhou, Fenli
    Bai, Bin
    Yan, Junya
    Guo, Yong
    Liu, Kun
    Li, Wenjiao
    Li, Renlong
    Yuan, Qiangqiang
    Zhang, Jiehao
    Lu, Yuanyuan
    Zhao, Xiaodi
    Ji, Gang
    Li, Mengbin
    Zhao, Qingchuan
    Wu, Kaichun
    Li, Zengshan
    Nie, Yongzhan
    CANCER MEDICINE, 2023, 12 (17): : 17613 - 17631
  • [43] Loss of HES-1 Expression Predicts a Poor Prognosis for Small Intestinal Adenocarcinoma Patients
    Kim, Jeong Won
    Jun, Sun-Young
    Ylaya, Kris
    Chang, Hee-Kyung
    Oh, Young-Ha
    Hong, Seung-Mo
    Chung, Joon-Yong
    Hewitt, Stephen M.
    FRONTIERS IN ONCOLOGY, 2020, 10
  • [44] The utility of the lineage specific immunohistochemical stains SATB2, CDX2, and villin, and the mucin glycoproteins MUC2, MUC5AC, and MUC6 to distinguish pulmonary invasive mucinous adenocarcinoma from metastatic colorectal carcinoma
    Rerkpichaisuth, Vilasinee
    Lau, Ryan P.
    Meyerson, Cherise
    Fishbein, Gregory A.
    HUMAN PATHOLOGY, 2024, 151
  • [45] Prognostic Value of LC3B and p62 Expression in Small Intestinal Adenocarcinoma
    Kim, Jeong-Won
    Jun, Sun-Young
    Kim, Joon-Mee
    Oh, Young-Ha
    Yoon, Ghilsuk
    Hong, Seung-Mo
    Chung, Joon-Yong
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (22)
  • [46] Differential Expression of β-Catenin, EGFR, CK7, CK20, MUC1, MUC2, and CDX2 in Intestinal and Pancreatobiliary-Type Ampullary Carcinomas
    Perysinakis, Iraklis
    Minaidou, Emilia
    Leontara, Vasileia
    Mantas, Dimitrios
    Sotiropoulos, Georgios C.
    Tsipras, Hercules
    Zografos, George N.
    Margaris, Ilias
    Kouraklis, Gregory
    INTERNATIONAL JOURNAL OF SURGICAL PATHOLOGY, 2017, 25 (01) : 31 - 40
  • [47] Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma - Application of CDX2, CK17, MUC1, and MUC2
    Chu, PG
    Schwarz, RE
    Lau, SK
    Yen, Y
    Weiss, LM
    AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2005, 29 (03) : 359 - 367
  • [48] Immunohistochemical Expression of CDX2, β-Catenin, and TP53 in Inflammatory Bowel Disease-associated Colorectal Cancer
    Laurent, Camille
    Svrcek, Magali
    Flejou, Jean-Francois
    Chenard, Marie-Pierre
    Duclos, Bernard
    Freund, Jean-Noel
    Reimund, Jean-Marie
    INFLAMMATORY BOWEL DISEASES, 2011, 17 (01) : 232 - 240
  • [49] Omeprazole prevents CDX2 and SOX9 expression by inhibiting hedgehog signaling in Barrett's esophagus cells
    Huang, Jiao
    Liu, Hua
    Sun, Tiantian
    Fang, Jing-Yuan
    Wang, Jilin
    Xiong, Hua
    CLINICAL SCIENCE, 2019, 133 (03) : 483 - 495
  • [50] Small-intestinal TG2-specific plasma cells at different stages of coeliac disease
    Minna Hietikko
    Outi Koskinen
    Kalle Kurppa
    Kaija Laurila
    Päivi Saavalainen
    Teea Salmi
    Tuire Ilus
    Heini Huhtala
    Katri Kaukinen
    Katri Lindfors
    BMC Immunology, 19